Constellation Pharmaceuticals (CNST) Q2 2020 Earnings Call Transcript

Thank you for standing by and welcome to the Constellation Pharmaceuticals Second Quarter 2020 earnings conference call. Good morning everyone, and welcome to this conference call to discuss Constellation's second quarter 2020 financial results and operational performance. Participating on our call this morning are Jigar Raythatha, Constellation's Chief Executive Officer, Dr. Jeff Humphrey, our new Chief Medical Officer, Dr. Patrick Trojer, our Chief Scientific Officer and Emma Reeve, our Chief Financial Officer.